Results
|
|
21.
|
Prognostic value of the age-adjusted International Prognostic Index in chemosensitive recurrent or refractory non-Hodgkin's lymphomas treated with high-dose BEAM therapy and autologous stem cell transplantation. [electronic resource] by
- Jabbour, E
- Peslin, N
- Arnaud, P
- Ferme, C
- Carde, P
- Vantelon, J M
- Bocaccio, C
- Bourhis, J H
- Koscielny, S
- Ribrag, V
Producer: 20080729
In:
Leukemia & lymphoma vol. 46
Availability: No items available.
|
|
|
22.
|
IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progression. [electronic resource] by
- DiNardo, C D
- Jabbour, E
- Ravandi, F
- Takahashi, K
- Daver, N
- Routbort, M
- Patel, K P
- Brandt, M
- Pierce, S
- Kantarjian, H
- Garcia-Manero, G
Producer: 20160915
In:
Leukemia vol. 30
Availability: No items available.
|
|
|
23.
|
High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL). [electronic resource] by
- Jabbour, E
- Koscielny, S
- Sebban, C
- Peslin, N
- Patte, C
- Gargi, T
- Biron, P
- Fermé, C
- Bourhis, J H
- Vantelon, J M
- Arnaud, P
- Ribrag, V
Producer: 20060912
In:
Leukemia vol. 20
Availability: No items available.
|
|
|
24.
|
Differential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy. [electronic resource] by
- Chen, Z
- Cortes, J E
- Jorgensen, J L
- Wang, W
- Yin, C C
- You, M J
- Jabbour, E
- Kantarjian, H M
- Medeiros, L J
- Hu, S
Producer: 20180212
In:
Leukemia vol. 30
Availability: No items available.
|
|
|
25.
|
Chronic myeloid leukemia--some topical issues. [electronic resource] by
- Mughal, T
- Cortes, J
- Cross, N C P
- Donato, N
- Hantschel, O
- Jabbour, E
- Kantarjian, H
- Melo, J V
- Skorski, T
- Silver, R T
- Goldman, J M
Producer: 20070831
In:
Leukemia vol. 21
Availability: No items available.
|
|
|
26.
|
Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate. [electronic resource] by
- Jabbour, E
- Kantarjian, H
- Jones, D
- Talpaz, M
- Bekele, N
- O'Brien, S
- Zhou, X
- Luthra, R
- Garcia-Manero, G
- Giles, F
- Rios, M B
- Verstovsek, S
- Cortes, J
Producer: 20061107
In:
Leukemia vol. 20
Availability: No items available.
|
|
|
27.
|
High prevalence of HBV genotype D in Syria and the clinical characteristics of hepatitis B e antigen-negative chronic hepatitis B. [electronic resource] by
- Antaki, N
- Haffar, S
- Ali Deeb, S
- Assaad, F
- Abou Harb, R
- Zeibane, N
- Nasserelddine, M
- Ibrahim, N
- Alhaj, N
- Jabbour, E
- Aaraj, R
- Antaki, F
- Kebbewar, K
Producer: 20091222
In:
Epidemiology and infection vol. 138
Availability: No items available.
|
|
|
28.
|
Failure is not fatal: long-term remission in refractory acute myeloid leukemia (AML) after graft failure of cord blood stem cells. [electronic resource] by
- Burger, J A
- Velev, N S
- Jabbour, E J
- Wierda, W G
- Ravandi, F
- Cortes, J E
- Kantarjian, H
- Nieto, Y L
- Shpall, E J
- Jorgensen, J L
Producer: 20100330
In:
Leukemia vol. 24
Availability: No items available.
|
|
|
29.
|
A randomized study of decitabine versus conventional care for maintenance therapy in patients with acute myeloid leukemia in complete remission. [electronic resource] by
- Boumber, Y
- Kantarjian, H
- Jorgensen, J
- Wen, S
- Faderl, S
- Castoro, R
- Autry, J
- Garcia-Manero, G
- Borthakur, G
- Jabbour, E
- Estrov, Z
- Cortes, J
- Issa, J-P
- Ravandi, F
Producer: 20130124
In:
Leukemia vol. 26
Availability: No items available.
|
|
|
30.
|
Myelodysplastic/myeloproliferative neoplasms, unclassifiable (MDS/MPN, U): natural history and clinical outcome by treatment strategy. [electronic resource] by
- DiNardo, C D
- Daver, N
- Jain, N
- Pemmaraju, N
- Bueso-Ramos, C
- Yin, C C
- Pierce, S
- Jabbour, E
- Cortes, J E
- Kantarjian, H M
- Garcia-Manero, G
- Verstovsek, S
Producer: 20140616
In:
Leukemia vol. 28
Availability: No items available.
|
|
|
31.
|
Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research Consortium. [electronic resource] by
- Zeidan, A M
- Al Ali, N
- Barnard, J
- Padron, E
- Lancet, J E
- Sekeres, M A
- Steensma, D P
- DeZern, A
- Roboz, G
- Jabbour, E
- Garcia-Manero, G
- List, A
- Komrokji, R
Producer: 20171017
In:
Leukemia vol. 31
Availability: No items available.
|
|
|
32.
|
Dynamic acquisition of FLT3 or RAS alterations drive a subset of patients with lower risk MDS to secondary AML. [electronic resource] by
- Takahashi, K
- Jabbour, E
- Wang, X
- Luthra, R
- Bueso-Ramos, C
- Patel, K
- Pierce, S
- Yang, H
- Wei, Y
- Daver, N
- Faderl, S
- Ravandi, F
- Estrov, Z
- Cortes, J
- Kantarjian, H
- Garcia-Manero, G
Producer: 20131210
In:
Leukemia vol. 27
Availability: No items available.
|
|
|
33.
|
Prognostic significance of 11q23 aberrations in adult acute myeloid leukemia and the role of allogeneic stem cell transplantation. [electronic resource] by
- Chen, Y
- Kantarjian, H
- Pierce, S
- Faderl, S
- O'Brien, S
- Qiao, W
- Abruzzo, L
- de Lima, M
- Kebriaei, P
- Jabbour, E
- Daver, N
- Kadia, T
- Estrov, Z
- Garcia-Manero, G
- Cortes, J
- Ravandi, F
Producer: 20130604
In:
Leukemia vol. 27
Availability: No items available.
|
|
|
34.
|
The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience. [electronic resource] by
- Jain, P
- Kantarjian, H
- Ravandi, F
- Thomas, D
- O'Brien, S
- Kadia, T
- Burger, J
- Borthakur, G
- Daver, N
- Jabbour, E
- Konopleva, M
- Cortes, J
- Pemmaraju, N
- Kelly, M A
- Cardenas-Turanzas, M
- Garris, R
- Faderl, S
Producer: 20140616
In:
Leukemia vol. 28
Availability: No items available.
|
|
|
35.
|
Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia. [electronic resource] by
- Ravandi, F
- Arana Yi, C
- Cortes, J E
- Levis, M
- Faderl, S
- Garcia-Manero, G
- Jabbour, E
- Konopleva, M
- O'Brien, S
- Estrov, Z
- Borthakur, G
- Thomas, D
- Pierce, S
- Brandt, M
- Pratz, K
- Luthra, R
- Andreeff, M
- Kantarjian, H
Producer: 20140911
In:
Leukemia vol. 28
Availability: No items available.
|
|
|
36.
|
A phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome. [electronic resource] by
- Daver, N
- Kantarjian, H
- Ravandi, F
- Estey, E
- Wang, X
- Garcia-Manero, G
- Jabbour, E
- Konopleva, M
- O'Brien, S
- Verstovsek, S
- Kadia, T
- Dinardo, C
- Pierce, S
- Huang, X
- Pemmaraju, N
- Diaz-Pines-Mateo, M
- Cortes, J
- Borthakur, G
Producer: 20160722
In:
Leukemia vol. 30
Availability: No items available.
|
|
|
37.
|
Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse. [electronic resource] by
- Boddu, P
- Jorgensen, J
- Kantarjian, H
- Borthakur, G
- Kadia, T
- Daver, N
- Alvarado, Y
- Pemmaraju, N
- Bose, P
- Naqvi, K
- Yilmaz, M
- Pierce, S
- Brandt, M
- DiNardo, C D
- Jabbour, E J
- Konopleva, M
- Garcia-Manero, G
- Cortes, J
- Ravandi, F
Producer: 20181211
In:
Leukemia vol. 32
Availability: No items available.
|
|
|
38.
|
Comparison of risk stratification tools in predicting outcomes of patients with higher-risk myelodysplastic syndromes treated with azanucleosides. [electronic resource] by
- Zeidan, A M
- Sekeres, M A
- Garcia-Manero, G
- Steensma, D P
- Zell, K
- Barnard, J
- Ali, N A
- Zimmerman, C
- Roboz, G
- DeZern, A
- Nazha, A
- Jabbour, E
- Kantarjian, H
- Gore, S D
- Maciejewski, J P
- List, A
- Komrokji, R
Producer: 20160719
In:
Leukemia vol. 30
Availability: No items available.
|
|
|
39.
|
Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors. [electronic resource] by
- Kongtim, P
- Adekola, K
- Milton, D R
- Ramlal, R
- Jimenez, A
- Chen, J
- Rondon, G
- Ahmed, S
- Kebriaei, P
- Betul, O
- Hosing, C M
- Popat, U
- Khouri, I
- Jabbour, E
- Cortes, J E
- Kantarjian, H M
- Champlin, R E
- Ciurea, S O
Producer: 20180612
In:
Leukemia vol. 31
Availability: No items available.
|
|
|
40.
|
Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL). [electronic resource] by
- Jain, P
- Aoki, E
- Keating, M
- Wierda, W G
- O'Brien, S
- Gonzalez, G N
- Ferrajoli, A
- Jain, N
- Thompson, P A
- Jabbour, E
- Kanagal-Shamanna, R
- Pierce, S
- Alousi, A
- Hosing, C
- Khouri, I
- Estrov, Z
- Cortes, J
- Kantarjian, H
- Ravandi, F
- Kadia, T M
Producer: 20180129
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 28
Availability: No items available.
|